Mechanism of the 5-hydroxytryptamine 2A receptor-mediated facilitation of synaptic activity in prefrontal cortex
- PMID: 17535909
- PMCID: PMC1887564
- DOI: 10.1073/pnas.0700436104
Mechanism of the 5-hydroxytryptamine 2A receptor-mediated facilitation of synaptic activity in prefrontal cortex
Abstract
Classic hallucinogens such as lysergic acid diethylamide are thought to elicit their psychotropic actions via serotonin receptors of the 5-hydroxytryptamine 2A subtype (5-HT(2A)R). One likely site for these effects is the prefrontal cortex (PFC). Previous studies have shown that activation of 5-HT(2A)Rs in this region results in a robust increase in spontaneous glutamatergic synaptic activity, and these results have led to the widely held idea that hallucinogens elicit their effect by modulating synaptic transmission within the PFC. Here, we combine cellular and molecular biological approaches, including single-cell 5-HT(2A)Rs inactivation and 5-HT(2A)R rescue over a 5-HT(2A)R knockout genetic background, to distinguish between competing hypotheses accounting for these effects. The results from these experiments do not support the idea that 5-HT(2A)Rs elicit the release of an excitatory retrograde messenger nor that they activate thalamocortical afferents, the two dominant hypotheses. Rather, they suggest that 5-HT(2A)Rs facilitate intrinsic networks within the PFC. Consistent with this idea, we locate a discrete subpopulation of pyramidal cells that is strongly excited by 5-HT(2A)R activation.
Conflict of interest statement
The authors declare no conflict of interest.
Figures





Similar articles
-
A major role for thalamocortical afferents in serotonergic hallucinogen receptor function in the rat neocortex.Neuroscience. 2001;105(2):379-92. doi: 10.1016/s0306-4522(01)00199-3. Neuroscience. 2001. PMID: 11672605
-
Repeated cocaine administration decreases 5-HT(2A) receptor-mediated serotonergic enhancement of synaptic activity in rat medial prefrontal cortex.Neuropsychopharmacology. 2009 Jul;34(8):1979-92. doi: 10.1038/npp.2009.10. Epub 2009 Feb 11. Neuropsychopharmacology. 2009. PMID: 19212317
-
Serotonergic facilitation of synaptic activity in the developing rat prefrontal cortex.J Physiol. 2004 May 1;556(Pt 3):739-54. doi: 10.1113/jphysiol.2003.051284. Epub 2004 Jan 23. J Physiol. 2004. PMID: 14742723 Free PMC article.
-
[Serotonergic control of prefrontal cortex].Rev Neurol. 2004 Sep 16-30;39(6):539-47. Rev Neurol. 2004. PMID: 15467993 Review. Spanish.
-
Serotonin and hallucinogens.Neuropsychopharmacology. 1999 Aug;21(2 Suppl):16S-23S. doi: 10.1016/S0893-133X(98)00135-3. Neuropsychopharmacology. 1999. PMID: 10432484 Review.
Cited by
-
Corticostriatal connectivity and its role in disease.Nat Rev Neurosci. 2013 Apr;14(4):278-91. doi: 10.1038/nrn3469. Nat Rev Neurosci. 2013. PMID: 23511908 Free PMC article. Review.
-
Molecular and Medical Aspects of Psychedelics.Int J Mol Sci. 2023 Dec 23;25(1):241. doi: 10.3390/ijms25010241. Int J Mol Sci. 2023. PMID: 38203411 Free PMC article. Review.
-
Presynaptic 5-HT2A-mGlu2/3 Receptor-Receptor Crosstalk in the Prefrontal Cortex: Metamodulation of Glutamate Exocytosis.Cells. 2022 Sep 28;11(19):3035. doi: 10.3390/cells11193035. Cells. 2022. PMID: 36230998 Free PMC article.
-
Molecular mechanisms of serotonergic action of the HIV-1 antiretroviral efavirenz.Pharmacol Res. 2016 Aug;110:10-24. doi: 10.1016/j.phrs.2016.04.028. Epub 2016 May 6. Pharmacol Res. 2016. PMID: 27157251 Free PMC article.
-
Me, myself, bye: regional alterations in glutamate and the experience of ego dissolution with psilocybin.Neuropsychopharmacology. 2020 Nov;45(12):2003-2011. doi: 10.1038/s41386-020-0718-8. Epub 2020 May 23. Neuropsychopharmacology. 2020. PMID: 32446245 Free PMC article. Clinical Trial.
References
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Miscellaneous